Renal biopsies of patients with podocytopathies, MCD or FSGS, had lower WT1 immunolabeling, which means lower number of podocytes compared to control group (p≤0.0001, F = 19.35, Tukey's post test, Fig 1A to 1D). Here, WT1 is linked to focal segmental glomerulosclerosis.